Pain Management After Shoulder Prosthesis: A Clinical Trial of Nerve Block and Local Infiltration
NCT ID: NCT01362075
Last Updated: 2014-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
74 participants
INTERVENTIONAL
2011-07-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interscalene and Combined Supra Scapular and Axillary Nerve Blocks in Rotator Cuff Repair
NCT01730573
Local Infiltration Analgesia Vs. Interscalene Block in Total Shoulder Arthorplasty
NCT04415931
Single Shot vs Continuous Interscalene Block for Rotator Cuff Repair
NCT01122745
Comparison of Pain Relief After Non Stimulating Interscalene Catheter Placement vs Stimulating Catheter Placement in Total Shoulder Arthroplasty.
NCT01122732
Rotator Cuff Pathway
NCT03717753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local infiltration analgesia
Local infiltration analgesia
150 ml ropivacaine, of which 100 ml is with adrenalin
Interscalene catheter
Interscalene catheter
7 ml ropivacaine interscalene block via catheter, subsequently given 5 ml/h and possibility of 5 ml bolus for the first 48 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local infiltration analgesia
150 ml ropivacaine, of which 100 ml is with adrenalin
Interscalene catheter
7 ml ropivacaine interscalene block via catheter, subsequently given 5 ml/h and possibility of 5 ml bolus for the first 48 hours.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* recent fracture near the shoulder
* allergic to amid-type local analgesics
* operation not under general anaesthesia
* incompetent, pregnant, below 18 or above 90 years old
* severe chronic neurogenic pain or sensory disturbances in the shoulder
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Aarhus University Hospital
OTHER
The Hede Nielsen Family Foundation
OTHER
Central Denmark Region
OTHER
The Danish Rheumatism Association
OTHER
Horsens Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Toftdahl Bjørnholdt
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen T Bjørnholdt, MD
Role: PRINCIPAL_INVESTIGATOR
Horsens Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital, Aarhus Hospital
Aarhus, Denmark, Denmark
Horsens Hospital
Horsens, Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-20110084
Identifier Type: OTHER
Identifier Source: secondary_id
KTB-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.